热门资讯> 正文

Zevra Therapeutics宣布CFO转型

2025-11-21 05:29

Zevra Therapeutics (NASDAQ:ZVRA) announced on Thursday that its CFO and Treasurer, R. LaDuane Clifton, will be stepping down from his position, effective December 31, 2025.
The company has initiated a search to identify its next CFO.

More on Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc. (ZVRA) Q3 2025 Earnings Call Transcript
Zevra signals European expansion for MIPLYFFA as U.S. coverage reaches 66% following robust Q3
Zevra Therapeutics, Inc. Q3 2025 Earnings Preview
Seeking Alpha’s Quant Rating on Zevra Therapeutics, Inc.
Historical earnings data for Zevra Therapeutics, Inc.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。